India Stem Cell Markets, Competition Forecast & Opportunities, 2026

Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "India Stem Cell Market by Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), by Application (Regenerative Medicine Vs. Drug Discovery & Development), by Technology, by Region, Competition Forecast & Opportunities, FY 2026" report has been added to ResearchAndMarkets.com's offering.

The Indian Stem Cell Market is expected to grow at over 12% CAGR during FY 2021 - FY 2026

Continuous advancements in tissue engineering is one of the prime factors boosting the Indian Stem Cell Market. Development of regenerative medicines coupled with growing cases of chronic and genetic diseases across the country are some of the other factors anticipated to drive the growth of the stem cell market during the forecast years.

Moreover, availability of funds from the government and certain organizations is estimated to bode well for the growth of the Indian Stem Cell Market over the next five years.

The Indian Stem Cell Market is segmented based on product type, application, technology, and region. Based on product type, the market can be categorized into adult, induced pluripotent, human embryonic and others. Out of these, the adult stem cells segment dominated the market until FY 2020 and is further expected to maintain its leading position in the market during the forecast period as well on account of reduced contamination risk associated with sub-culturing.

Moreover, its compatibility with the human body is expected to drive the segment growth over the coming years. Additionally, less requirement for production labor is boosting the growth of adult stem cells segment.

Major players operating in the Indian Stem Cell Market include Reliance Life Sciences, LifeCell International Private Limited, Cryobanks International India Private Limited, Cordlife India, StemCyte India Therapeutics Private Limited, ReeLabs Private Limited, Stempeutics Research Private Limited, among others.

The companies are focussing on extensive research and developments activities in order to stay competitive in the market. Other competitive strategies include formation of alliances and partnerships.

Years considered for this report:

• Historical Years: FY 2016 - FY 2019

• Base Year: FY 2020

• Estimated Year: FY 2021

• Forecast Period: FY 2022 - FY 2026

Key Topics Covered:

1. Product of Interest Introduction: Stem Cell

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. India Stem Cell Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Adult; Induced Pluripotent; Human Embryonic; Others)
5.2.2. By Application (Regenerative Medicine Vs. Drug Discovery & Development)
5.2.3. By Technology (Cell Acquisition; Cell Production; Cryopreservation; Expansion & Subculture)
5.2.4. By Region (North, South, East, West)
5.2.5. By Company
5.3. Market Attractiveness Index

6. India Stem Cell Acquisition Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Adult; Induced Pluripotent; Human Embryonic; and Others)
6.2.2. By Type (Bone Marrow Harvest; Umbilical Blood Cord; and Apheresis)

7. India Stem Cell Production Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type (Adult; Induced Pluripotent; Human Embryonic; and Others)
7.2.2. By Type (Therapeutic cloning; In vitro fertilization; Cell culture; and Isolation)

8. India Stem Cell Cryopreservation Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type (Adult; Induced Pluripotent; Human Embryonic; and Others)

9. India Stem Cell Expansion & Sub-culture Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type (Adult; Induced Pluripotent; Human Embryonic; and Others)

10. Supply Chain Analysis

11. Import & Export Analysis

12. Market Dynamics
12.1. Drivers/Opportunities
12.2. Challenges/Restraints

13. Market Trends & Developments

14. Policy & Regulatory Landscape

15. India Economic Profile

16. Competitive Landscape
16.1. Company Profiles
16.1.1. Reliance Life Sciences
16.1.2. LifeCell International Private Limited
16.1.3. Cryobanks International India Private Limited
16.1.4. Cordlife India
16.1.5. StemCyte India Therapeutics Private Limited
16.1.6. ReeLabs Private Limited
16.1.7. Stempeutics Research Private Limited

17. Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/tis8s1

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900